SG Americas Securities
EW icon

SG Americas Securities’s Edwards Lifesciences EW Stock Holding History

SG Americas Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,000
Closed -$2K – 3138
2025
Q1 		$2K Sell
12,000
-30,000
-71% -$2.15M ﹤0.01% 3432
2024
Q4 		$10K Sell
42,000
-517,600
-92% -$36.2M ﹤0.01% 3043
2024
Q3 		$592K Buy
559,600
+529,600
+1,765% +$38.5M ﹤0.01% 1536
2024
Q2 		$122K Buy
+30,000
New +$2.66M ﹤0.01% 2432
2020
Q2 		– Sell
-90,000
Closed -$68K – 3733
2020
Q1 		$68K Buy
+90,000
New +$6.49M ﹤0.01% 3110

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

SG Americas Securities's EW Position: Q1 2026 in Review

SG Americas Securities increased its Edwards Lifesciences (EW) stake by 65% in Q1 2026, buying an estimated $31.9M and bringing the position to 980,609 shares worth $78.5M. The position accounts for 0.08% of the portfolio, ranked #185.

SG Americas Securities first reported a position in EW in Q2 2013 and has held it in 52 quarters since. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • SG Americas Securities held 980,609 shares of Edwards Lifesciences worth $78.5M as of Q1 2026.
  • SG Americas Securities bought 387,127 Edwards Lifesciences shares in Q1 2026, an estimated $31.9M.
  • Edwards Lifesciences made up 0.08% of SG Americas Securities's portfolio in Q1 2026, its #185 holding.
  • SG Americas Securities first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.